H. Buerkle et al., EFFECT OF CONTINUOUS SPINAL REMIFENTANIL INFUSION ON BEHAVIOR AND SPINAL GLUTAMATE RELEASE EVOKED BY SUBCUTANEOUS FORMALIN IN THE RAT, British Journal of Anaesthesia, 80(3), 1998, pp. 348-353
Injection of formalin into the hind paw of the rat evokes a biphasic n
ociceptive behavioural response, which is considered to be an animal m
odel of postoperative pain in humans. The initial response (phase 1) i
s caused by activation of peripheral nociceptors and is followed by a
second phase attributed to ongoing activity in primary afferents and i
ncreased sensitivity of dorsal horn neurones. The latter effect is tho
ught to result from glutamate-mediated N-methyl-D-aspartate receptor a
ctivation. In studies to date it has been difficult to discriminate me
chanisms underlying phase 1 and phase 2 events because of the long-las
ting half-times of intrathecally administered opioids. To further unde
rstanding of the opioid pharmacology of the two different phases of th
e formalin test, we have studied behavioural activity and spinal gluta
mate release after intrathecal administration of remifentanil, a new s
hort-lasting mu opioid. Intrathecal remifentanil 3 mu g mu l(-1) min(-
1) delivered during phase 1 inhibited behavioural response during phas
e 1 (100%), but did not abolish subsequent phase 2 behavioural activit
y completely (67 (12) %). Intrathecal remifentanil administered separa
tely in phase 1 and phase 2 revealed a similar ED50 (0.2 mu g mu l(-1)
min(-1)) for inhibition of the behavioural responses. In vivo, spinal
microdialysis showed incomplete reduction in glutamate concentrations
in response to intrathecal remifentanil administration; this in turn
inhibited phase 1 behavioural responses. Therefore we contend that sup
ramaximal doses of intrathecal remifentanil sufficient to inhibit phas
e 1 activity still permitted sufficient glutamate release to allow spi
nal facilitation. Incomplete suppression of spinal excitatory neurotra
nsmitter release by intrathecal opioids is consistent with spinal wind
-up that is triggered during phase 1 and results in phase 2 afferent d
rive. This might reflect one of the mechanisms underlying postoperativ
e pain.